University of California, San Francisco: Diabetes Mellitus, Type 1 trials

The registry lists 11 Diabetes Mellitus, Type 1 studies with University of California, San Francisco as lead sponsor. 2 are open to participants now and 4 have results posted.

Phase 1 2Phase 2 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Automated Insulin for Management of Intrapartum GlycemiaRecruitingNCT06883344Not applicable
• Commercial or Open Source Closed Loop Impact on Pregnancy StudyRecruitingNCT06654713
• Extended Bolus for Meals in a Closed-loop SystemCompletedNCT05454891Not applicableResults posted
• Behavioral Approaches to Reducing Diabetes Distress and Improving Glycemic ControlCompletedNCT04016558Not applicableResults posted
• Imatinib Treatment in Recent Onset Type 1 Diabetes MellitusCompletedNCT01781975Phase 2Results posted
• T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal TregsCompletedNCT01210664Phase 1Results posted
• Device Use Reimagined Through Education And MentorshipActive, not recruitingNCT06546930Not applicable
• Reducing Distress And Improving Glycemic Control In Adults With Type 1 DiabetesCompletedNCT02175732Not applicable
• Audio Health Engagement Analysis in Diabetes: The AHEAD StudyCompletedNCT01938807Not applicable
• Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes MellitusCompletedNCT00501709Phase 1/2
• Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes MellitusCompletedNCT00187564Not applicable